1. Araki S., Ikegawa S., Yi S., Ando Y., Murakami T., Miyazaki A.
Familial amyloidotic polyneuropathy in Japan, Review of recent studies in Kumamoto district Bol Hosp Hosp Geral St Antonio Porto, 3, 29-42 (1989)

2. Ando Y., Inoue M., Hirata E., Morino Y., Araki S.
Dynamic aspect of glutathione metabolism in paraquat-treated rats
Life Sci Adv Biochem, 7, 259-263 (1989)

3. Ando Y., Ando E., Inoue M.
Role of relative oxygens in corneal inflammation: Analysis by acylated SOD derivatives with high affinity for plasma membrane surface
CytoPro Biology, 10, 254-258 (1990)

4. Ando Y., Araki S.
Autonomic disorders in familial amyloidotic polyneuropathy
Adv Clin Neurosci, 2, 197-205 (1992)

5. Ando Y., Araki S., Ando M.
Transthyretin and familial amyloidotic polyneuropathy
Intern Med, 32, 920-922 (1993)

6. Ando Y., Yonehara T., Suhr O., Uchino M., Ando M.
Effet de l'hypotension orthostatique surles flux sanguins carebraux
Arteres Veines, 15, 140-145 (1996)

7. Ando Y., Suhr O., Tashima K., Uchino M., Ando M.
Liver transplantation in Japanese patients with familial amyloidotic polyneuropathy
Lancet, 350, 593-594 (1997)

8. el-Salhy M., Nihlin N., Ando Y., Suhr O.
The neuroendocrine system and gastrointestinal complications in patients with familial amyloidosis and polyneuropathy
Scand J Gastroenterol,32, 849-854 (1997)

9. Ando Y., Suhr .O
Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP)
Amyloid, 5, 288-300 (1998)

10. Ando Y., Suhr O., el-Salhy M.
Oxidatve stress and amyloidosis
Histol Histopathol, 13, 845-850 (1998)

11. Ikeda S., Nakazato M., Ando Y., Sobue G.
Familial amyloidotic polyneruoapthy in Japan: Clinical and genetic heterogeneity
Neurology, 58, 1001-1007 (2002)

12. Ikeda S., Takei Y., Tokuda T., Nakazato M., Ando Y.
Clinical and pathological findings of non-Val30Met TTR type familial amyloidotic polyneuropathy in Japan
Amyloid, 10, S39-S47 (2003)

13. Ando Y.
New therapeutic approaches for familial amyloidotic polyneuropathy (FAP)
Amyloid, 10, S55-S66 (2003)

14. Sobue G., Koike H., Misu K., Hattori N., Yamamoto M., Ikeda S., Ando Y., Nakazato M., Inukai A.
Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan
Amyloid, 10, S32-S38 (2003)

15. Nakamura M., Ando Y.
Application of gene therapy for FAP
Expert Opin Ther Pat, 10, 1621-1627 (2004)

16. Ando Y., Nakamura M., Araki S.
Transthyretin related familial amyloidotic polyneuropathy
Arch Neurol, 62, 1057-1062 (2005)

17. Ando Y.
Liver transplantation and new therapeutic approches for familial amyloidotic polyneuropathy (FAP)
Med Mor Morphol, 38, 142-154 (2005)

18. Ando Y., Nakamura M.
Gene therapy by liver transplantation and single stranded oligonucleotides (SSOs) in familial amyloidotic polyneuropathy (FAP)
Curre Pharmacogen, 4, 79-86 (2006)

19. Ando Y., Ueda M.
Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis
Front Biosci, 13, 5548-5558 (2008)

20. Araki S., Ando Y.
Transthyretin-related familial amyloidotic polyneuropathy.
Proc. Japn. Acad Ser B, 86, 694-706 (2010)

21. Jono H., Ando Y.
Midkine: A novel prognostic biomarker for cancer
Cancers, 2, 624-641 (2010)

22. Ando Y.
FAP is a candidate disease in patients with undetermined polyneuropathy.
Intern Med, 49, 1841-1842 (2010)

23. Ando Y., Ueda M.
Proteomics for transthyretin (TTR) related amyloidosis
Curr Proteomics, 8, 237-246 (2011)

24. Ando Y.
Therapy of ATTR amyloidosis. Perspectives
Amyloid, 18(Suppl 1）, 182-184 (2011)

25. Ando Y., Ueda M.
Diagnostics and therapeutic approaches to transthyretin amloidosis
Curr Med Chem, 19, 2312-2323 (2012)

26. Ando Y.
A report on VIIIth international symposium on familial amyloidotic polyneuropathy and VIIth international symposium on liver transplantation in familial amyloidotic polyneuropathy
Amyloid, 19 (Suppl 1), 1-2 (2012)

27. Ando Y., Coelho T., Berk JL., Cruz MW., Ericzon BG., Ikeda S., Lewis WD., Obici L., Plante-Bordeneuve P., Rapezzi C., Said Salvi F.
Guideline of transthyretin-related hereditary amyloidosis for clinicians
Orphanet J Rare Dis, 8, 31 (2013)

28. Ueda M., Ando Y.
Recent advances in transthyretin amyloidosis therapy
Transl Neurodegner, 3, 19 (2014)

29. Hawkins PN., Ando Y., Dispenzeri A., Gonzalez-Duarte A., Adams D., Suhr OB.
Evolving landscape in the management of transthyretin amyloidosis
Ann Med, 47, 625-638 (2015)

30. Sekijima Y., Ueda M., Koike H., Misawa S., Ishii T., Ando Y.
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
Orphanet J Rare Dis, 13, 6 (2018)